U.S., Aug. 23 -- ClinicalTrials.gov registry received information related to the study (NCT07135973) titled 'A Study to Investigate Safety of Belumosudil in Participants Aged 12 Years and Above, With Chronic Graft-versus-host Disease (cGVHD)' on Aug. 14.

Brief Summary: This is an interventional phase IV clinical study which is single-arm study for assessing the safety of belumosudil in Indian patients who are12 years and older.

Study details include:

* The study duration will be up to 12 months per participant.

* The treatment duration will be up to 24 weeks.

* The number of visits will be 7.

Study Start Date: Aug. 29

Study Type: INTERVENTIONAL

Condition: Chronic Graft Versus Host Disease

Intervention: DRUG: Belumosudil

Pharmace...